The dosimetric impact of heterogeneity corrections in high-dose-rate 192Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans

Heterogeneity corrections on high-dose rate plans were found to have only a small dosimetric impact over TG-43-based dose calculations for both conventional Point-A and volume-optimized plans.